Shawn Seong

Company: Shaperon Inc.

Job title: Chief Executive Officer

Seminars:

Targeting the Inflammasome to Treat Chronic Inflammatory Skin Diseases: Clinical & Preclinical Advances in Atopic Dermatitis and Alopecia Areata 1:30 pm

Presenting Phase 2 clinical trial data demonstrating the efficacy and safety of a novel inflammasome inhibitor targeting GPCR19 in patients with mild-to-moderate atopic dermatitis Highlighting preclinical results in canine models using oral formulation showing potent suppression of NLRP3 inflammasome activation, supporting the development of 2nd generation compounds. Sharing early-stage data in alopecia areata showing restoration…Read more

day: Day One PM